The National Academies of Sciences, Engineering, and Medicine While computational reproducibility in scientific research is generally expected when the original data and code are available, lack of ability to replicate a previous study -- or obtain consistent results looking at the same scientific...

Scientific Consultations - TREATMENT AND REHABILITATION INTERVENTIONS IN CLINICALLY SPECIFIC POPULATIONS AND SETTINGS - 09.12.2015 Dr. Igor Koutsenok, Professor of Psychiatry, University of California San Diego, School of Medicine. The opinions expressed in this video represent those of the author...

"Molecular Imaging in SUD: Opportunities for Translation into Basic and Clinical Neuroscience" from the Cellular Biology of Drug Addiction course 8/9/2013

This webcast, Why addiction is a “disease” and why it’s important, defines what is a disease and why it is important to emphasize addiction/substance use disorder (SUD) as a brain disease from a neurobiological perspective as well as from a biopsychosocial perspective. Discussion will also include...

CBS: Dr. Nora Volkow, the head of the National Institute on Drug Abuse, has revolutionized how science and medicine view addiction: as a disease, not a character defect. Morley Safer reports.

This webinar is part of the NIDA CTN's "Using Mobile Technologies in the CTN" series. Find more information, and links to the other webinars in the series, here: http://ctndisseminationlibrary.org/display/1173.htm

Neuroscientist Nora Volkow, director of the National Institute on Drug Abuse at the NIH, applies a lens of addiction to the obesity epidemic.